Adrienne Farid compensation by year
Century Therapeutics Summary Compensation Table · all 6 fiscal years held| Component | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Salary | $379,250 | $416,367 | $456,042 | $490,365 | $513,050 | $333,348 |
| Bonus | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $0 | $203,000 | $127,560 | $71,120 |
| Option awards | $78,877 | $945,301 | $902,334 | $836,627 | $547,413 | $51,240 |
| Non-equity incentive | $114,330 | $161,498 | $182,417 | $166,724 | $215,481 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $11,400 | $11,600 | $12,200 | $13,200 | $13,800 | $533,515 |
| Total | $583,857 | $1,534,766 | $1,552,993 | $1,709,916 | $1,417,304 | $989,403 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Century Therapeutics, Inc. DEF 14A filed April 27, 2026, accession 0001104659-26-049489, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Century Therapeutics, Inc. filed document, accession 0001104659-26-049489. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2026.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 24,000 | $24,240 | — |
| RSU | 12,306 | $12,429 | — |
| Option | 28,444 | — | $13.15 |
| Option | 146,000 | — | $5.32 |
| Option | 25,957 | — | $7.27 |
| Option | 71,098 | — | $4.64 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Century Therapeutics, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Century Therapeutics’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Chad Cowan | Chief Scientific Officer | $1,167,015 |
| Adrienne Farid · this page | Former Chief Development Officer | $989,403 |
| Gregory Russotti | Chief Technology and Manufacturing Officer and former Interim President and Chief Executive Officer | $912,320 |
Adrienne Farid's compensation dossier, Century Therapeutics
You have read Adrienne Farid's totals and holdings. The dossier adds each equity grant Century Therapeutics disclosed for Adrienne Farid and Century Therapeutics's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full Century Therapeutics compensation record
free company briefThis page is one person within Century Therapeutics's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Century Therapeutics's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Century Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order IPSC
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.